Premium
Limited efficacy of atezolizumab and bevacizumab for hepatocellular carcinoma previously treated with tyrosine kinase inhibitor
Author(s) -
Yamada Tomoharu,
Minami Tatsuya,
Tateishi Ryosuke,
Koike Kazuhiko
Publication year - 2021
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.15010
Subject(s) - medicine , atezolizumab , post graduate , graduate students , bevacizumab , hepatocellular carcinoma , family medicine , library science , medical education , cancer , chemotherapy , pembrolizumab , immunotherapy , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom